Quality assurance study on gastric cancer in Germany;Qualitätssicherungsstudie zum magenkarzinom in Deutschland

Onkologe

Volumn 14, Issue 4, 2008, Pages 396-402

  Meyer, L ^a   Ridwelski, K ^b   Meyer, F ^c   Gastinger, I ^d   Lippert, H ^c  

^a Childrens Hospital   (Germany)

^b Stadtisches Klinikum Magdeburg   (Germany)

^c UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^d CARL THIEM KLINIKUM   (Germany)

Author keywords

Care research; Gastric carcinoma; Multimodal therapy; Quality assurance

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL;

CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL; GERMANY; HEALTH CARE QUALITY; HUMAN; LONG TERM CARE; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; QUALITY CONTROL; REVIEW; STOMACH CANCER; STOMACH CARCINOMA; SURVIVAL RATE;

EID: 44149104876     PISSN: 09478965     EISSN: 14330415     Source Type: Journal    
DOI: 10.1007/s00761-008-1340-2     Document Type: Review

References (18)

1. Böttcher K, Roder JD, Busch R et al. (1993) Epidemiologie des Magenkarzinoms aus chirurgischer Sicht. Dtsch Med Wochenschr 118: 729-736
2. Böttcher K, Siewert JR, Roder JD et al. (1994) Risiko der chirurgischen Therapie des Magenkarzinoms in Deutschland. Ergebnisse der Deutschen Magencarcinom-Studie 1992. Chirurg 65: 298-306
3. Cunningham D, Allum WH, Stenning SP et al. MAGIC Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11-20
4. Gastinger I, Koch A, Marusch F et al. (2002) Die Bedeutung prospektiver multizentrischer Beobachtungsstudien für den Erkenntnisgewinn in der Chirurgie. Chirurg 73: 161-166
5. Hansson LE, Ekstrom AM, Bergstrom R, Nyren O (2000) Surgery for stomach cancer in a defined Swedish population: current practices and operative results. Swedish Gastric Cancer Study Group. Eur J Surg 166: 787-795
6. MacDonald JS, Smalley SR, Benedetti J et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adencarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730
7. Markus B, Pinter G (2001) Partial versus total gastrectomy in the surgical treatment of stomach cancer. Magy Seb 54: 361-367
8. Meyer C, Lozac'h P, Rohr S et al. French Association of Surgery (2002) Gastric cancer: the French survey. Acta Gastroenterol Belg 65: 161-165
9. Meyer L, Meyer F, Dralle H et al. (2005) Insufficiency risk of esophagojejunal anstomosis after total abdominal gastrectomy for gastric carcinoma. Langenbecks Arch Surg 390: 510-516
10. Meyer L, Steinert R, Nowak L et al. (2005) Prospektive Multizenterstudie zur Chirurgie des Magenkarzinoms - Ein Beitrag zur Klinischen Versorgungsforschung. Zentralbl Chir 130: 97-103
11. Ott K, Fink U, Becker K et al. (2003) Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 21: 4604-4610
12. Sendler A, Etter M, Böttcher K, Siewert JR (2002) Resektionsausmaß in der Chirurgie des Magenkarzinoms. Chirurg 73: 316-324
13. Seulin P, Carrere N, Bloom E et al. (2000) Stomach cancer: have changes in surgical strategy influenced the results? 20-year retrospective study. Ann Chir 125: 131-136
14. Siewert JR, Böttcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg 228: 449-461
15. Uhl W, Wente MN, Büchler MW (2000) Surgical clinical studies and their practical realization. Chirurg 71: 615-625
16. www.zvfk.de-content-e89-e441-e444-memorandumzurVersorgungsforschung1.3. pdf
17. www.zvfk.de-content-e89-e441-e857-MemorandumII.pdf
18. Ychou M, Pignon JP, Lasser P et al. (2006) Phase III preliminary results of preoperative fluorouracil (F) and cisplatin (P) versus surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC 94012-FFCD 9703 trial. #4026 ASCO 2006